- Home
- MTLS vs TKNO Comparison
MTLS vs TKNO Comparison
Compare MTLS & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- TKNO
- Stock Information
- Founded
- MTLS 1990
- TKNO 1996
- Country
- MTLS Belgium
- TKNO United States
- Employees
- MTLS N/A
- TKNO N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- MTLS Technology
- TKNO Health Care
- Exchange
- MTLS Nasdaq
- TKNO Nasdaq
- Market Cap
- MTLS 349.7M
- TKNO 256.9M
- IPO Year
- MTLS 2014
- TKNO 2021
- Fundamental
- Price
- MTLS $5.13
- TKNO $4.35
- Analyst Decision
- MTLS
- TKNO
- Analyst Count
- MTLS 0
- TKNO 0
- Target Price
- MTLS N/A
- TKNO N/A
- AVG Volume (30 Days)
- MTLS 127.2K
- TKNO 224.0K
- Earning Date
- MTLS 10-23-2025
- TKNO 08-07-2025
- Dividend Yield
- MTLS N/A
- TKNO N/A
- EPS Growth
- MTLS N/A
- TKNO N/A
- EPS
- MTLS 0.11
- TKNO N/A
- Revenue
- MTLS $311,850,851.00
- TKNO $38,923,000.00
- Revenue This Year
- MTLS $2.98
- TKNO $9.52
- Revenue Next Year
- MTLS $7.09
- TKNO $15.20
- P/E Ratio
- MTLS $48.31
- TKNO N/A
- Revenue Growth
- MTLS 2.98
- TKNO 11.40
- 52 Week Low
- MTLS $3.93
- TKNO $4.00
- 52 Week High
- MTLS $9.69
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- MTLS 47.90
- TKNO 43.35
- Support Level
- MTLS $5.01
- TKNO $4.22
- Resistance Level
- MTLS $5.32
- TKNO $4.94
- Average True Range (ATR)
- MTLS 0.18
- TKNO 0.29
- MACD
- MTLS 0.02
- TKNO -0.00
- Stochastic Oscillator
- MTLS 52.08
- TKNO 16.75
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.